Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 22036 AL 22050

Why docosahexaenoic acid and aspirin supplementation could be useful in women as a primary prevention therapy against Alzheimer's disease?

Pomponi MF, Gambassi G, Pomponi M, Di Gioia A, Masullo C.

Ageing Res Rev. 2011 Jan;10(1):124-31. doi: 10.1016/j.arr.2010.09.003. Epub 2010 Oct 8.

Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern?

Thoonsen H, Richard E, Bentham P, Gray R, van Geloven N, De Haan RJ, Van Gool WA, Nederkoorn PJ.

Stroke. 2010 Nov;41(11):2690-2. doi: 10.1161/STROKEAHA.109.576975. Epub 2010 Oct 7.

Peri-operative risk management in patients with Alzheimer's disease

Di Nino G, Adversi M, Samolsky Dekel BG, Fodale V, Rosa G, Melotti RM.

J Alzheimers Dis. 2010;22 Suppl 3:121-7. doi: 10.3233/JAD-2010-101299.

Postoperative cognitive dysfunction: toward the Alzheimer's disease pathomechanism hypothesis

Bilotta F, Doronzio A, Stazi E, Titi L, Fodale V, Di Nino G, Rosa G.

J Alzheimers Dis. 2010;22 Suppl 3:81-9. doi: 10.3233/JAD-2010-100825.

Current treatments for patients with Alzheimer disease

Osborn GG, Saunders AV.

J Am Osteopath Assoc. 2010 Sep;110(9 Suppl 8):S16-26.

Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome

Patel A, Rees SD, Kelly MA, Bain SC, Barnett AH, Thalitaya D, Prasher VP.

Neurosci Lett. 2011 Jan 7;487(2):144-8. doi: 10.1016/j.neulet.2010.10.010. Epub 2010 Oct 12.

New developments in the diagnosis of dementia

Eschweiler GW, Leyhe T, Klöppel S, Hüll M.

Dtsch Arztebl Int. 2010 Oct;107(39):677-83. doi: 10.3238/arztebl.2010.0677. Epub 2010 Oct 1.

Predicting cognitive decline in Alzheimer's disease: an integrated analysis

Lopez OL, Schwam E, Cummings J, Gauthier S, Jones R, Wilkinson D, Waldemar G, Zhang R, Schindler R.

Alzheimers Dement. 2010 Nov;6(6):431-9. doi: 10.1016/j.jalz.2010.04.003.

Genetics of Alzheimer disease

Bekris LM, Yu CE, Bird TD, Tsuang DW.

J Geriatr Psychiatry Neurol. 2010 Dec;23(4):213-27. doi: 10.1177/0891988710383571.

Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?

Saxena U.

Expert Opin Ther Targets. 2010 Dec;14(12):1273-7. doi: 10.1517/14728222.2010.528285.

How useful is the IQCODE for discriminating between Alzheimer's disease, mild cognitive impairment and subjective memory complaints?

Sikkes SA, van den Berg MT, Knol DL, de Lange-de Klerk ES, Scheltens P, Uitdehaag BM, Klein M, Pijnenburg YA.

Dement Geriatr Cogn Disord. 2010;30(5):411-6. doi: 10.1159/000321697. Epub 2010 Nov 11.

Hip fracture risk and subsequent mortality among Alzheimer's disease patients in the United Kingdom, 1988-2007

Baker NL, Cook MN, Arrighi HM, Bullock R.

Age Ageing. 2011 Jan;40(1):49-54. doi: 10.1093/ageing/afq146. Epub 2010 Nov 18.

Late onset Alzheimer's disease in older people

Isik AT.

Clin Interv Aging. 2010 Oct 11;5:307-11. doi: 10.2147/CIA.S11718.

Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?

Humpel C.

Exp Gerontol. 2011 Apr;46(4):225-32. doi: 10.1016/j.exger.2010.11.032. Epub 2010 Nov 26.

Development and validation of the Memory Orientation Screening Test (MOST™): A better screening test for dementia

Clionsky MI, Clionsky E.

Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):650-6. doi: 10.1177/1533317510386216.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias